MRI and blood tests for lung nodules found on screening
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether MRI scans and blood-related biomarkers can help better understand lung nodules found during routine lung cancer screening. It may help doctors decide which nodules need closer follow-up versus less intensive monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and understand the consent form and choose to join
- You are in a lung cancer screening program and meet high-risk age and smoking history guidelines
- Your screening CT scan (LDCT) found one or more lung nodules measuring 6 mm or larger
- You do not currently have a known active cancer diagnosis or lung cancer symptoms
- You can safely have an MRI (no certain metal implants/metal fragments, not pregnant or nursing, and you can lie still)
- You can follow the visit instructions, including lying flat, staying still, and following breathing directions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using an MRI combined with a special type of CT scan can effectively monitor lung nodules over time. It may help people at high risk for lung cancer avoid repeated radiation from regular CT scans.
This trial uses advanced CT and MRI scans to make lung cancer screening more accurate and safer. It aims to better find and understand lung nodules, helping doctors decide if they are cancerous without unnecessary procedures.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.